Preferred Name |
Blinatumomab |
|
Synonyms |
|
|
ID |
http://www.phoc.org.cn/pmo/class/PMO_00026259 |
|
Database_Cross_Reference |
NDDF:015799 NDFRT:N0000191284 MTH:NOCODE PDQ:CDR0000487684 MTHSPL:4FR53SIF3A NCI:C62528 MMSL:30709 NCI_FDA:4FR53SIF3A RXNORM:1597258 MEDCIN:344148 DRUGBANK:DB09052 SNOMEDCT_US:716122004 MMSL:d08312 ATC:L01XC19 VANDF:4033958 MSH:C510808 |
|
label |
Blinatumomab |
|
MCID |
MC00979278 |
|
PMOID |
PMO:00026259 |
|
prefixIRI |
pmo:PMO_00026259 |
|
prefLabel |
Blinatumomab |
|
Synonym |
blinatumomab (medication) Anti-CD19 x Anti-CD3 Bispecific Monoclonal Antibody MT-103 blinatumomab BLINATUMOMAB chemotherapeutics blinatumomab Blinatumomab (substance) Anti-CD19/Anti-CD3 Recombinant Bispecific Monoclonal Antibody MT103 |
|
Tree Number |
T6.4.4.1.2.14.9 |
|
subClassOf |
Create mapping